View in EDS

Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial.

Saved in:
Bibliographic Details
Title: Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial.
Authors: Martínez E; Department of Infectious Diseases, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Reial Acadèmia de Medicina de Catalunya, Barcelona, Spain. Electronic address: estebanm@clinic.cat., Watanabe M; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA, USA., Hoffman R; Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Zanni MV; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Pozniak A; Chelsea and Westminster Hospital and London School of Hygiene & Tropical Medicine, London, UK., Shakil SS; Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA., McCallum S; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Chu SM; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Srinivasa S; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Malvestutto CD; Division of Infectious Diseases, Ohio State University Medical Center, Columbus, OH, USA., Fichtenbaum CJ; Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA., Bloomfield GS; Department of Medicine, Duke Global Health Institute and Duke Clinical Research Institute, Duke University, Durham, NC, USA., Sponseller CA; Kowa Pharmaceuticals America, Montgomery, AL, USA., Lu AB; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Aberg JA; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Currier JS; Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., Ribaudo HJ; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA, USA., Grinspoon SK; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Corporate Authors: REPRIEVE Investigators
Source: The lancet. HIV [Lancet HIV] 2026 May; Vol. 13 (5), pp. e327-e337.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42067280
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martínez+E%22">Martínez E</searchLink>; Department of Infectious Diseases, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Reial Acadèmia de Medicina de Catalunya, Barcelona, Spain. Electronic address: estebanm@clinic.cat.<br /><searchLink fieldCode="AU" term="%22Watanabe+M%22">Watanabe M</searchLink>; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hoffman+R%22">Hoffman R</searchLink>; Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zanni+MV%22">Zanni MV</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pozniak+A%22">Pozniak A</searchLink>; Chelsea and Westminster Hospital and London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Shakil+SS%22">Shakil SS</searchLink>; Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22McCallum+S%22">McCallum S</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chu+SM%22">Chu SM</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Srinivasa+S%22">Srinivasa S</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Malvestutto+CD%22">Malvestutto CD</searchLink>; Division of Infectious Diseases, Ohio State University Medical Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Fichtenbaum+CJ%22">Fichtenbaum CJ</searchLink>; Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Bloomfield+GS%22">Bloomfield GS</searchLink>; Department of Medicine, Duke Global Health Institute and Duke Clinical Research Institute, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Sponseller+CA%22">Sponseller CA</searchLink>; Kowa Pharmaceuticals America, Montgomery, AL, USA.<br /><searchLink fieldCode="AU" term="%22Lu+AB%22">Lu AB</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lu+MT%22">Lu MT</searchLink>; Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Aberg+JA%22">Aberg JA</searchLink>; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Currier+JS%22">Currier JS</searchLink>; Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Douglas+PS%22">Douglas PS</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ribaudo+HJ%22">Ribaudo HJ</searchLink>; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Grinspoon+SK%22">Grinspoon SK</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22REPRIEVE+Investigators%22">REPRIEVE Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101645355%22">The lancet. HIV</searchLink> [Lancet HIV] 2026 May; Vol. 13 (5), pp. e327-e337.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101645355 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3018 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523018%22">23523018 </searchLink><i>NLM ISO Abbreviation: </i>Lancet HIV <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42067280
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2352-3018(26)00036-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e327
    Titles:
      – TitleFull: Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martínez E
      – PersonEntity:
          Name:
            NameFull: Watanabe M
      – PersonEntity:
          Name:
            NameFull: Hoffman R
      – PersonEntity:
          Name:
            NameFull: Zanni MV
      – PersonEntity:
          Name:
            NameFull: Pozniak A
      – PersonEntity:
          Name:
            NameFull: Shakil SS
      – PersonEntity:
          Name:
            NameFull: McCallum S
      – PersonEntity:
          Name:
            NameFull: Chu SM
      – PersonEntity:
          Name:
            NameFull: Srinivasa S
      – PersonEntity:
          Name:
            NameFull: Malvestutto CD
      – PersonEntity:
          Name:
            NameFull: Fichtenbaum CJ
      – PersonEntity:
          Name:
            NameFull: Bloomfield GS
      – PersonEntity:
          Name:
            NameFull: Sponseller CA
      – PersonEntity:
          Name:
            NameFull: Lu AB
      – PersonEntity:
          Name:
            NameFull: Lu MT
      – PersonEntity:
          Name:
            NameFull: Aberg JA
      – PersonEntity:
          Name:
            NameFull: Currier JS
      – PersonEntity:
          Name:
            NameFull: Douglas PS
      – PersonEntity:
          Name:
            NameFull: Ribaudo HJ
      – PersonEntity:
          Name:
            NameFull: Grinspoon SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3018
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: The lancet. HIV
              Type: main
ResultId 1